deltatrials
Unknown PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT02446795

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial (QUASAR)

Sponsor: Clinical Research Technology S.r.l.

Conditions Kidney Cancer Renal Cell Carcinoma
Interventions Isoquercetin Placebo Sunitinib
Updated 8 times since 2017 Last updated: Jan 16, 2017 Started: Nov 30, 2016 Primary completion: Dec 31, 2017 Completion: Dec 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Kidney Cancer and Renal Cell Carcinoma, this trial is ongoing. The trial is conducted by Clinical Research Technology S.r.l. and has accumulated 8 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotNot Yet Recruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotRecruiting~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshotRecruiting~Feb 2019 – ~Jan 2021 · 23 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE1/PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1/PHASE2

    Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE1_PHASE2

  5. Feb 2019 — Jan 2021 [monthly]

    Unknown Status PHASE1_PHASE2

    Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

  1. Jun 2018 — Feb 2019 [monthly]

    Recruiting PHASE1_PHASE2

  2. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Not Yet Recruiting → Recruiting

  3. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

    First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Clinical Research Technology S.r.l.
  • Consorzio Oncotech
  • Quercegen Pharmaceuticals
Data source: Consorzio Oncotech

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations